Posted inDiabetes & Endocrinology news
Beta Cell Glucose Sensitivity May Predict Response to New-Onset Type 1 Diabetes Therapies
A pooled analysis of nine type 1 diabetes trials found that beta cell glucose sensitivity may better predict response to disease-modifying therapy than C-peptide alone, helping identify patients most likely to benefit.